THE HUMAN DATA SCIENCE COMPANY
LIVE

Serial Number

87983383

Owner

QUINTILES IMS INCORPORATED

Attorney

Cynthia Johnson Walden

Filing Date

May 31, 2017

Add to watchlist:

No watchlists yet
View on USPTO

THE HUMAN DATA SCIENCE COMPANY Trademark

Serial Number: 87983383 • Registration: 6175670

THE HUMAN DATA SCIENCE COMPANY is a trademark filed by QUINTILES IMS INCORPORATED on May 31, 2017. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

QUINTILES IMS INCORPORATED (34 trademarks)

83 WOOSTER HEIGHTS ROAD
DANBURY, CT 06810

Entity Type: 03

IQVIA INC. (81 trademarks)

100 IMS DRIVE
PARSIPPANY, NJ 07054

Entity Type: 03

Trademark Details

Filing Date

May 31, 2017

Registration Date

October 13, 2020

Published for Opposition

November 27, 2018

Goods & Services

Education and training services, namely, conducting training programs, seminars, classes, conferences and workshops in the pharmaceutical, medical, healthcare, and life sciences fields; Educational and training services, namely, conducting conferences to train physicians and other medical providers on conducting clinical trials; Education and training services, namely, providing non-downloadable webinars, webcasts and digital content in the pharmaceutical, medical, healthcare, and life sciences fields; Non-downloadable online publications in the nature of brochures, reports, or white papers in the pharmaceutical, medical, healthcare, and life sciences fields

Market analysis and research services; Business market consulting; Marketing consulting; Business consulting and information services; Business consulting services and business management consulting in the pharmaceutical, medical, healthcare, and life sciences fields; Business process outsourcing services in the pharmaceutical, medical, healthcare, and life sciences fields; Providing a web-based online portal that provides customer access to business information in the fields of pharmaceutical, medical, healthcare, and life sciences; Public policy research services; Computerized database management and data processing services in the pharmaceutical, medical, healthcare, and life sciences fields; Sales representatives in the pharmaceutical, medical, healthcare, and life sciences fields; Business consultation and management regarding marketing activities, launching of new products and services, and sales; Personnel recruitment and placement; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of pharmaceutical, medical, healthcare, and life sciences companies to assist them with clinical research, clinical trials and applications for drug, biologic and device approval; Providing independent review of clinical trials for business purposes; Maintaining a registry of patients, namely, compilation of patient information into computer databases; Business consulting and business management consultation services related to healthcare management and electronic health records (EHR) management; Business management consulting and advisory services in pharmaceutical, medical, healthcare, and life sciences fields; Advertising, marketing and promotional services in the pharmaceutical, medical, healthcare, and life sciences fields; Business management services, namely, quality management services of patient-care programs; Recruitment services, namely, advertising clinical trials, recruiting patients, and placing patients for participation in clinical trials for testing of drugs, biologics and devices; Business consulting in the fields of healthcare management

Regulatory compliance legal research in the field of design and development of drugs, devices, biologics and methodologies used in the pharmaceutical industry, and medical industry; Regulatory compliance consulting in the pharmaceutical, medical, healthcare, and life sciences fields; Providing regulatory information, namely, legal information regarding compliance with pharmaceutical, medical, healthcare, and life sciences fields regulations; Providing regulatory implementation services relating to the development, validation, and production of drugs, biologics and devices; Providing an online, interactive computer database in the field of regulatory affairs relating to the pharmaceutical, medical, healthcare, and life sciences fields

Providing pharmaceutical, medical, healthcare, and life sciences information to others

Providing online, non-downloadable software for providing pharmaceutical, medical, healthcare, and life sciences information and analysis; Software as a service (SAAS) services featuring software for providing, collecting, analyzing pharmaceutical, medical, healthcare, and life sciences information; Computer services, namely, providing on-line, non-downloadable computer software used for accessing, collecting, managing, tracking, analyzing, and reporting data in the pharmaceutical, medical, healthcare, and life sciences fields; Research and analysis related to pharmaceutical, medical, healthcare, and life sciences information; Computer services, namely, designing, developing and managing application software and databases related to pharmaceutical, medical, healthcare, and life sciences information; Computer software development for others; Clinical research, clinical testing, and laboratory testing services in the pharmaceutical, medical, healthcare, and life sciences fields; Product development consultation in the pharmaceutical, medical, healthcare, medical and life sciences fields; Conducting clinical trials for others; Providing temporary use of on-line non-downloadable software for use in healthcare and electronic health record (EHR) management; Information technology consulting services; Computer software consultation services in the pharmaceutical, medical, healthcare, and life sciences fields; Scientific research in the pharmaceutical, medical, healthcare, and life sciences fields; Computer services, namely, creating computer network-based indexes and databases of information; Providing electronic data capture (EDC) and management systems, namely, providing temporary use of online, non-downloadable software for collection and management of healthcare and life sciences data; Non-downloadable computer software for collecting, managing, and analyzing clinical trial data; Providing an on-line interactive database featuring information in the pharmaceutical, medical, healthcare, and life sciences fields; Providing information relating to the development, validation, and regulatory approval of drugs, biologics and devices

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 13, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Oct 13, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 10, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 9, 2020 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Aug 24, 2020 SUPC
DIVISIONAL PROCESSING COMPLETE
Aug 24, 2020 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 3, 2020 AITU
USE AMENDMENT FILED
Jun 25, 2020 IUAF
DIVISIONAL REQUEST RECEIVED
Jun 25, 2020 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Jun 25, 2020 ERTD
TEAS STATEMENT OF USE RECEIVED
Jun 25, 2020 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 17, 2020 EXRA
SOU EXTENSION 1 GRANTED
Jan 15, 2020 EX1G
SOU EXTENSION 1 FILED
Jan 15, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 15, 2020 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 16, 2019 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jun 6, 2019 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Dec 26, 2018 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 27, 2018 NPUB
PUBLISHED FOR OPPOSITION
Nov 27, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 7, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 18, 2018 CNSA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 17, 2018 ASGN
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 28, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 28, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 28, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 6, 2018 GNRN
NON-FINAL ACTION E-MAILED
Apr 6, 2018 GNRT
NON-FINAL ACTION WRITTEN
Apr 6, 2018 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 16, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 16, 2018 CRFA
ASSIGNED TO LIE
Mar 14, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 1, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 1, 2017 GNRN
NON-FINAL ACTION E-MAILED
Sep 1, 2017 GNRT
NON-FINAL ACTION WRITTEN
Sep 1, 2017 CNRT
ASSIGNED TO EXAMINER
Aug 30, 2017 DOCK
TEAS VOLUNTARY AMENDMENT RECEIVED
Aug 21, 2017 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 7, 2017 NWOS
NEW APPLICATION ENTERED
Jun 3, 2017 NWAP